# MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/monarch-1-a-phase-ii-study-of-abemaciclib-a-cdk4-and-cdk6-inhibitor-as-a-single/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Maura N. Dickler,Sara M. Tolaney,Hope S. Rugo,Javier Cortés,Véronique Dièras,Debra A. Patt,Hans Wildiers,Clifford A. Hudis,Joyce O’Shaughnessy,Esther Zamora,Denise A. Yardley,Martin Frenzel,Andrew Koustenis,José Baselga |
| Citations | 687 |
| DOI | 10.1158/1078-0432.ccr-17-0754 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://clincancerres.aacrjournals.org/content/clincanres/23/17/5218.full.pdf |
| OpenAlex ID | https://openalex.org/W2617437931 |
| PMID | 28533223 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Maura N. Dickler](https://scholariq.org/researchers/maura-n-dickler/)
- [Joyce O’Shaughnessy](https://scholariq.org/researchers/joyce-o-shaughnessy/)
- [Clifford A. Hudis](https://scholariq.org/researchers/clifford-a-hudis/)

## Paper journal

- [Clinical Cancer Research](https://scholariq.org/journals/clinical-cancer-research/)

## Paper primary topic

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Paper topics

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.